A comparison of a new mucolytic n-acetylcysteine l-lysinate with n-acetylcysteine: Airway epithelial function and mucus changes in dog

Pulmonary Pharmacology

Volumn 8, Issue 6, 1995, Pages 259-265

  Tomkiewicz, R P ^a,b   App, E M ^c   De Sanctis, G T ^d   Coffiner, M ^e   Maes, P ^e   Rubin, B K ^b   King, M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Laboratories SMB and Galephar   (Belgium)

Author keywords

Glycollate; Mucociliary clearance; Mucus viscoelasticity; Nacystelyn; Sodium pentosan polysulphate

Indexed keywords

ACETYLCYSTEINE; ACETYLCYSTEINE DERIVATIVE; CHLORIDE ION; MUCOLYTIC AGENT; N ACETYLCYSTEINE LYSINATE; NACYSTELYN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CILIARY MOTILITY; CONTROLLED STUDY; DISULFIDE BOND; DOG; FEMALE; FROG; INHALATIONAL DRUG ADMINISTRATION; MALE; MUCOCILIARY CLEARANCE; MUCUS; NONHUMAN; PALATE; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT MUCOSA; TRACHEA MUCUS; VISCOELASTICITY; WATER CONTENT;

ACETYLCYSTEINE; ADMINISTRATION, INHALATION; ANIMALS; BRONCHI; DOGS; EXPECTORANTS; FEMALE; LYSINE; MALE; MUCOCILIARY CLEARANCE; MUCUS; TRACHEA; VISCOSITY;

EID: 0029552705     PISSN: 09520600     EISSN: None     Source Type: Journal    
DOI: 10.1006/pulp.1995.1035     Document Type: Article

References (41)

1. King M, Rubin BK, Rheology of airway mucus: relationship with clearance function. In: Takashima T, Shimura S, eds. Airway Secretion: Physiological Bases for the Control of Mucus Hypersecretion (Lung Biology in Health and Disease Series). New York: Marcel Dekker, 1994: 283-314.
2. Tomkiewicz RP, Biviji A A, King M. Effects of oscillating air flow on rheological properties and clearability of mucous gel simulants. Biorheology 1994; 31: 511-520.
3. Sheffner A L. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine. Ann NY Acad Sci 1963; 106: 298-310.
4. Tomkiewicz R P, App E M, Coffiner M, Maes P, Fossion J, King M. Mucolytic treatment with N-acetylcysteine L-lysinate metered dose inhaler aerosol: canine airway epithelial function changes. Eur Respir J 1994; 7: 81-87.
5. Boucher R C. Human airway ion transport. Part one. Am J Respir Crit Care Med 1994; 150: 271-281.
6. Ikeda K, Sasaki T, Shimura S, Satoh M, Ishihara H, Sasaki H, Takishima T, Saitoh Y, Nishijama A. Effect of surfactant in bioelectric properties of canine tracheal epithelium. Respir Physiol 1990; 81: 41-49
7. Bennett W D, Olivier K N, Zeman K L, Hohneker K H, Boucher R C, Knowles M R, Acute effects of aerosolized uridine 5'-triphosphate plus amiloride on mucociliary clearance in cystic fibrosis. Am J Respir Crit Care Med 1994; 149: A670.
8. Iravani J, Melville GN, Horstman G. N-acetylcysteine and mucociliary activity in mammalian airways. Drug Res 1978; 28: 250-254.
9. Liglitowler JE, Lighluwler NM. Comparative mucolytic studies on dithiothreitol, N-acetylcysteine and L-cysteine on human respiratory mucus in vitro and their effects on the rate of flow of mucus in the exposed trachea of rat on topical application. Arch Int Pharmacodyn 1971; 189: 53-58.
10. Knauf H, Haag K, Liibcke R, Berger E, Gerok W. Determination of short-circuit current in the in vivo perfused rat colon. Am J Physiol 1984; 246: G151-G158.
11. App EM, King M. Airway transepithelial electric potential difference measurements in vivo guided by bronchoscopy in animals and in man. Eur Respir J 1989; 2: 278s.
12. App E M, Zayas J G, King M, Rheology of mucus and transepithelial potential difference: small airways versus trachea. Eur Respir J 1993; 6: 67-75.
13. King M, Phillips D M, Gross D, Vartian V, Chang H K, Zidulka A. Enhanced mucus clearance with high frequency chest wall compression. Am Rev Respir Dis 1983; 128: 511-515.
14. King M, Kelly S, Cosio M. Alteration of airway reactivity by mucus. Respir Physiol 1985; 62: 47-59.
15. King M, Engel LA, Macklem PT. Effect of pentobarbital anesthesia on rheology and transport of canine tracheal mucus. J Appl Physiol 1979; 46: 504-510.
16. Rubin B K, Ramirez O, Zayas J G, Finegan B, King M. Collection and analysis of respiratory mucus from individuals without lung disease. Am Rev Respir Dis 1990; 141: 1040-1043.
17. King M. Magnetic microrheometer. In: Braga PC, Allegra L, eds. Methods in Bronchial Mucology. New York: Raven Press, 1988: 73-83.
18. Tomkiewicz R P, App E M, Ramirez O E, Zayas J G, Boucher R C, Knowles M R, Church N, King M. Amiloride inhalation therapy in cystic fibrosis: its influence on ion content, hydration and rheology of sputum. Am Rev Respir Dis 1993; 148: 1002-1007.
19. Holma B, Tomkiewicz R P, King M. Comparison of N-acetylcysteine and its lysine derivative Nacystelyn on ciliary beating frequency in vivo in frog. Am Rev Respir Dis 1992; 145: A800.
20. De Sanctis G T, Tomkiewicz R P, Rubin B K, Schurch S, King M, Exogenous surfactant in vivo enhances mucociliary clearance in the dog. Eur Respir J 1994; 7: 1616-1621.
21. Tomkiewicz R P, App E M, Shennib H, Ramirez O E, Nguyen D, King M. Airway mucus and epithelial function in a canine model of single lung autotransplantation. Chest 1995; 107: 261-266.
22. Boucher R C, Bromberg P A, Gatzy J T. Airway transepithelial electric potential in vivo: species and regional differences. J Appl Physiol 1980; 48: 169-176.
23. Man S F P, Adams G K II, Proctor D F. Effects of temperature, relative humidity, and mode of breathing on canine airway secretions. J Appl Physiol 1979; 46: 205-210.
24. Pillai R S, Chandra T, Miller I F, Lloyd-Still J, Yeates D B. Work of adhesion of respiratory tract mucus. J Appl Physiol 1992; 72: 1604-1610.
25. App EM, Baran D, Tomkiewicz RP, Hochstrasser K, Coffiner M, Fossion J, Maes P, King M. A pilot study of an aerosolized new mucolytic agent Nacystelyn for the treatment of lung disease in cystic fibrosis. Am J Respir Crit Care Med 1994; 149: A676.
26. Lutz R J, Litt M, Chakrin LW. Physical-chemical factors in mucus rheology. In: Gabelnick H L, Litt M, eds. Rheology of Biological Systems. Springfield, IL: CC Thomas, 1973: 119-157.
27. Quinton PM. Viscosity versus composition in airway pathology. Am J Respir Crit Care Med 1994; 149: 6-7.
28. Girod S, Zahm J M, Plotkowski C, Beck G, Puchelle E. Role of the physicochemical properties of mucus in the protection of the respiratory epithelium. Eur Respir 1992; 5: 477-487.
29. Boucher R C, Stutts M J, Gatzy J T. Regional differences in bioelectric properties and ion flow in excised canine airways, J A.ppl Physiol 1981; 51; 706-714.
30. Kilburn KH. A hypothesis for pulmonary clearance and its implications. Am Rev Respir Dis 1968; 98: 449-463.
31. King M, Tomkiewicz R P, App E M. Regional variation in transepithelial potential difference (PD) and response to amiloride in canine airways. FASEB J 1991; 5: A1399.
32. Boucher R C. Human airway ion transport. Part two. Am J Respir Crit Care Med 1994; 150: 581-593.
33. Cloutier M M, Guernsey L, Mattes P, Koeppen B. Duramycin enhances chloride secretion in airway epithelium. Am J Physiol 1990; 259: C450-C454.
34. King M, De Sanctis G T, Tomkiewicz R P, Holma B, Schurch S. Improvement of tracheal mucus clearance in dogs following administration of artificial surfactant. Am Rev Respir Dis 1993; 147: A99.
35. Tomkiewicz RP, App EM, Boyd WA, Holma B, Coffiner M, Maes P, Deboeck A, King M. Airway function in dogs after aerosol treatment with related mucolytics: N-acetylcysteine L-lysinate and N-acetylcysteine. Eur Respir J 1994; 7: 128s.
36. Hardy J G, Everard M L, Coffiner M, Fossion J, Lung deposition of a Nacystelyn metered dose inhaler formulation. J Aerosol Med 1993; 6: 37-14.
37. Boat T F, Mathews L W. Chemical composition of human tracheobronchial secretions. In: Dulfano M J, ed. Sputum: Fundamentals and Clinical Pathology. Springfield, IL: CC Thomas, 1973: 243-274.
38. Holma B, Hegg P O. pH and protein dependent buffer capacity and viscosity of respiratory mucus. Their interrelationships and influence on health. Sci Total Environ 1989; 84: 71-82.
39. Ventresca G P, Cicchetti V, Ferrari V. Drugs breaking mucous polymeric structure. Acetylcysteine. In; Braga P C, Allegra L, eds. Drugs in Bronchial Mucology. New York: Raven Press, 1989: 77-102
40. Dasgupta B. King M. Molecular basis for mucolytic therapy. Can Respir J 1995; 2: 223-230.
41. Marriott C, Ingham S, Coffiner M, Fossion J, Maes P. Determination of the mode of action of a novel mucolytic agent Nacystelyn. Eur Respir J 1993; 6: 438s.